Raphael Dolin

14.5k total citations · 2 hit papers
152 papers, 8.5k citations indexed

About

Raphael Dolin is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Raphael Dolin has authored 152 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 71 papers in Infectious Diseases and 45 papers in Virology. Recurrent topics in Raphael Dolin's work include HIV Research and Treatment (37 papers), Viral gastroenteritis research and epidemiology (34 papers) and Herpesvirus Infections and Treatments (27 papers). Raphael Dolin is often cited by papers focused on HIV Research and Treatment (37 papers), Viral gastroenteritis research and epidemiology (34 papers) and Herpesvirus Infections and Treatments (27 papers). Raphael Dolin collaborates with scholars based in United States, Germany and Canada. Raphael Dolin's co-authors include Richard G. Wyatt, Albert Z. Kapikian, Thomas S. Thornhill, Robert M. Chanock, Richard C. Reichman, H P Madore, Anthony R. Kalica, Charles A. Alford, Richard J. Whitley and George J. Galasso and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Raphael Dolin

150 papers receiving 7.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Visualization by Immune Electron Microscopy of a 27-nm Particle Associated with Acute Infectious Nonbacterial Gastroenteritis

1972 753 citations Albert Z. Kapikian, Raphael Dolin et al. profile →
Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis

1977 498 citations Raphael Dolin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Raphael Dolin	4.4k	3.7k	2.2k	1.3k	1.2k	152	8.5k
Kenneth McIntosh	5.8k 1.3×	5.3k 1.4×	2.7k 1.3×	1.5k 1.2×	862 0.7×	195	11.2k
Guido Antonelli	2.3k 0.5×	2.5k 0.7×	1.0k 0.5×	1.4k 1.1×	580 0.5×	371	7.4k
M. R. Hilleman	2.6k 0.6×	5.2k 1.4×	596 0.3×	1.9k 1.5×	703 0.6×	278	9.2k
Robert F. Garry	3.2k 0.7×	1.9k 0.5×	1.0k 0.5×	1.3k 1.0×	365 0.3×	227	7.1k
Maria Rosaria Capobianchi	4.6k 1.0×	2.8k 0.8×	1.6k 0.7×	1.9k 1.5×	279 0.2×	396	9.5k
Jack T. Stapleton	2.9k 0.7×	4.6k 1.2×	1.9k 0.9×	1.2k 0.9×	514 0.4×	182	9.2k
Massimo Clementi	2.8k 0.6×	3.7k 1.0×	1.9k 0.9×	972 0.8×	207 0.2×	325	9.8k
Yuxian He	9.0k 2.0×	1.6k 0.4×	3.0k 1.4×	2.2k 1.7×	1.9k 1.6×	153	11.9k
Katja C. Wolthers	3.9k 0.9×	2.7k 0.7×	693 0.3×	963 0.8×	1.1k 0.9×	134	6.6k
Robert B. Belshe	4.9k 1.1×	12.2k 3.3×	3.0k 1.4×	4.8k 3.7×	577 0.5×	256	16.7k

Countries citing papers authored by Raphael Dolin

Since Specialization

Citations

This map shows the geographic impact of Raphael Dolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Dolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Dolin more than expected).

Fields of papers citing papers by Raphael Dolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Dolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Dolin. The network helps show where Raphael Dolin may publish in the future.

Co-authorship network of co-authors of Raphael Dolin

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Dolin. A scholar is included among the top collaborators of Raphael Dolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Dolin. Raphael Dolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barouch, Dan H., Jinyan Liu, Lauren Peter, et al.. (2012). Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001). The Journal of Infectious Diseases. 207(2). 248–256. 75 indexed citations

Walsh, Stephen R. & Raphael Dolin. (2011). Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Review of Vaccines. 10(8). 1221–1240. 68 indexed citations

Seaman, Michael S., Marissa B. Wilck, Lindsey R. Baden, et al.. (2010). Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax. The Journal of Infectious Diseases. 201(9). 1353–1360. 26 indexed citations

Wilck, Marissa B., Michael S. Seaman, Lindsey R. Baden, et al.. (2010). Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration. The Journal of Infectious Diseases. 201(9). 1361–1370. 55 indexed citations

Grandpre, Lauren E., Jonathan S. Duke‐Cohan, Bonnie A. Ewald, et al.. (2009). Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine. 27(10). 1549–1556. 18 indexed citations

Dolin, Raphael & Peter F. Wright. (1999). Viral infections of the respiratory tract. Marcel Dekker eBooks. 20 indexed citations

Spino, Cathie, James O. Kahn, Raphael Dolin, & John Phair. (1997). Predictors of Survival in HIV-Infected Persons With 50 or Fewer CD4 Cells/mm3. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(5). 346–355. 17 indexed citations

Mascola, John R., S W Snyder, O. S. Weislow, et al.. (1996). Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 173(2). 340–348. 354 indexed citations

Welles, Seth L., J. Brooks Jackson, Belinda Yen‐Lieberman, et al.. (1996). Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy. The Journal of Infectious Diseases. 174(4). 696–703. 74 indexed citations

10.

Walker, Mary Clare, Patricia Fast, Barney S. Graham, Robert B. Belshe, & Raphael Dolin. (1995). Phase I/II Preventive Vaccine Trials: Conference Summary. AIDS Research and Human Retroviruses. 11(10). 1279–1285. 11 indexed citations

11.

Demeter, Lisa M., et al.. (1995). Development of Zidovudine Resistance Mutations in Patients Receiving Prolonged Didanosine Monotherapy. The Journal of Infectious Diseases. 172(6). 1480–1485. 32 indexed citations

12.

Graham, Barney S., Geoffrey J. Gorse, David H. Schwartz, et al.. (1994). Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus. The Journal of Infectious Diseases. 170(4). 782–786. 29 indexed citations

13.

Keefer, Michael C., Barney S. Graham, Robert B. Belshe, et al.. (1994). Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans. AIDS Research and Human Retroviruses. 10(12). 1713–1723. 46 indexed citations

14.

Daher, N, M. C. Keefer, Richard C. Reichman, Raphael Dolin, & Norbert J. Roberts. (1993). Persisting Human Immunodeficiency Virus Type 1 gp160-Specific Human T Lymphocyte Responses Including CD8+ Cytotoxic Activity after Receipt of Envelope Vaccines. The Journal of Infectious Diseases. 168(2). 306–313. 33 indexed citations

15.

Lambert, John S., Mindell Seidlin, Fred Valentine, Richard C. Reichman, & Raphael Dolin. (1993). Didanosine: Long-Term Follow-Up of Patients in a Phase 1 Study. Clinical Infectious Diseases. 16(Supplement_1). S40–S45. 9 indexed citations

16.

Belshe, Robert B., M L Clements, Raphael Dolin, et al.. (1993). Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection. The Journal of Infectious Diseases. 168(6). 1387–1395. 61 indexed citations

17.

Pai, Sudhakar M., Umesh Shukla, Thaddeus H. Grasela, et al.. (1992). Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related Complex. The Journal of Clinical Pharmacology. 32(3). 242–247. 21 indexed citations

18.

Madore, H P, et al.. (1992). Field Trial of Rhesus Rotavirus or Human-Rhesus Rotavirus Reassortant Vaccine of VP7 Serotype 3 or 1 Specificity in Infants. The Journal of Infectious Diseases. 166(2). 235–243. 52 indexed citations

19.

Reichman, Richard C., Gary J. Badger, Grégory Mertz, et al.. (1984). Treatment of Recurrent Genital Herpes Simplex Infections with Oral Acyclovir. A Controlled Trial. Obstetrical & Gynecological Survey. 39(9). 595–596. 3 indexed citations

20.

Dolin, Raphael. (1978). Norwalk Agent-like Particles Associated with Gastroenteritis in Human Beings. Journal of the American Veterinary Medical Association. 173(5). 615–619. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact